» Articles » PMID: 30315646

Correlations of Serum Hormones and Bone Mineral Density with Fracture and Balance Ability of Postmenopausal Patients and Effects of Calcitriol

Overview
Journal Med Sci Monit
Date 2018 Oct 14
PMID 30315646
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND The aim of this study was to analyze the correlations of serum hormones and bone mineral density (BMD) with fracture and balance ability of postmenopausal patients and effects of calcitriol on them. MATERIAL AND METHODS The clinical data of 164 postmenopausal female patients with osteoporosis (OP) treated in our hospital were retrospectively analyzed. RESULTS The incidence rates of OVCF, balance index score (BIS), front-back ratio (FBR), and right-left ratio (RLR) in the normal BMD group, reduced BMD group, and OP group showed increasing trends, and there were statistically significant differences in comparisons among groups (p<0.05). The levels of serum estradiol (E2) and progesterone (P) in the OVCF group were lower than those in the non-OVCF group, and there were statistically significant differences in comparisons between the 2 groups (p<0.05). However, there was no statistically significant difference in the comparison of serum luteinizing hormone (LH) level between the 2 groups (p>0.05). BIS, FBR, and RLR were negatively correlated with E2 and testosterone (T) (p<0.05). With the prolongation of calcitriol treatment time, BIS, FBR, and RLR gradually decreased, but T value gradually increased. At 6 months and 12 months after intervention, BIS, FBR, and RLR had significant differences compared to those before the experiment (p<0.05). (5) Total hip BMD, height, age, and body mass index (BMI) were the independent factors affecting SDI. CONCLUSIONS Hip BMD, age, height, and BMI are significantly correlated with OVCF. Calcitriol treatment can increase lumbar BMD and improve balance ability, and these effects become more obvious with prolongation of intervention time.

Citing Articles

Impact of vitamin D on the prognosis after spinal cord injury: A systematic review.

Wang L, Gan J, Wu J, Zhou Y, Lei D Front Nutr. 2023; 10:920998.

PMID: 36866055 PMC: 9973556. DOI: 10.3389/fnut.2023.920998.


Current Concepts in the Management of Vertebral Compression Fractures.

Hoyt D, Urits I, Orhurhu V, Orhurhu M, Callan J, Powell J Curr Pain Headache Rep. 2020; 24(5):16.

PMID: 32198571 DOI: 10.1007/s11916-020-00849-9.


Effects of Rhizoma Drynariae Cataplasm on Fracture Healing in a Rat Model of Osteoporosis.

Guo W, Shi K, Xiang G, Lu D, Dou H, Xie C Med Sci Monit. 2019; 25:3133-3139.

PMID: 31030207 PMC: 6503747. DOI: 10.12659/MSM.914568.

References
1.
Pillai A, Eranki V, Shenoy R, Hadidi M . Age related incidence and early outcomes of hip fractures: a prospective cohort study of 1177 patients. J Orthop Surg Res. 2011; 6:5. PMC: 3033339. DOI: 10.1186/1749-799X-6-5. View

2.
Leslie W, Schousboe J . A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world. Curr Osteoporos Rep. 2011; 9(3):129-40. DOI: 10.1007/s11914-011-0060-5. View

3.
Kanis J, McCloskey E, Johansson H, Cooper C, Rizzoli R, Reginster J . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2012; 24(1):23-57. PMC: 3587294. DOI: 10.1007/s00198-012-2074-y. View

4.
Poiana C, Carsote M, Radoi V, Mihai A, Capatina C . Prevalent osteoporotic fractures in 622 obese and non- obese menopausal women. J Med Life. 2015; 8(4):462-6. PMC: 4656953. View

5.
Wong C, McGirt M . Vertebral compression fractures: a review of current management and multimodal therapy. J Multidiscip Healthc. 2013; 6:205-14. PMC: 3693826. DOI: 10.2147/JMDH.S31659. View